{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:09:48Z","timestamp":1790672988724,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jaci.2021.07.027","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T02:58:01Z","timestamp":1628391481000},"page":"1060-1068.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A novel approach for studying mast cell\u2013driven disorders: Mast cells derived from induced pluripotent stem cells"],"prefix":"10.1016","volume":"149","author":[{"given":"Yanyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Fernandez Vallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Frischbutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kolkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherezade","family":"Mo\u00f1ino-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Stachelscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Streu-Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-481X","authenticated-orcid":false,"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.07.027_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","article-title":"Mast cells as drivers of disease and therapeutic targets","volume":"39","author":"Siebenhaar","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molimm.2014.04.001","article-title":"Human mast cell tryptase in biology and medicine","volume":"63","author":"Vitte","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.07.027_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","article-title":"Mast cell activation syndromes","volume":"140","author":"Akin","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-pathol-052016-100312","article-title":"Pathogenesis and pathology of mastocytosis","volume":"12","author":"Metcalfe","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2021.07.027_bib6","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1111\/1523-1747.ep12468966","article-title":"Ultrastructural and immunohistochemical characterization of normal mast cells at mutiple body sites","volume":"96","author":"Weidner","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.07.027_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000487538","article-title":"The staining of mast cells: a historical overview","volume":"176","author":"Ribatti","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/mi.2014.131","article-title":"Potential effector and immunoregulatory functions of mast cells in mucosal immunity","volume":"8","author":"Reber","year":"2015","journal-title":"Mucusal Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2021.07.027_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaci.2013.02.011","article-title":"Human mast cells arise from a common circulating progenitor","volume":"132","author":"Maaninka","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0091-6749(96)80162-X","article-title":"Human basophil\/mast cell releasability, XI: heterogeneity of the effects of contrast media on mediator release","volume":"97","author":"Stellato","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jim.2008.04.019","article-title":"Seven week culture of functional human mast cells from buffy coat preparations","volume":"336","author":"Holm","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2021.07.027_bib14","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2009-08-237206","article-title":"Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseases","volume":"115","author":"Kovarova","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.07.027_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2010.12.1101","article-title":"Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional Fc\u03b5RI","volume":"127","author":"Laidlaw","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000365729","article-title":"A ten year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line","volume":"164","author":"Kirshenbaum","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1600-0625.2010.01103.x","article-title":"Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells\u2014drastically reduced levels of tryptase and chymase in mast cell lines","volume":"19","author":"Guhl","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2021.07.027_bib18","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddy186","article-title":"Drug screening for human genetic diseases using iPSC models","volume":"27","author":"Elitt","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2021.07.027_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3858\/emm.2012.44.3.015","article-title":"Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery","volume":"44","author":"Jang","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jaci.2021.07.027_bib20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cell.2008.01.015","article-title":"Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming","volume":"132","author":"Jaenisch","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2021.07.027_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrg2700","article-title":"Induced pluripotent stem cells and reprogramming: seeing the science through the hype","volume":"10","author":"Belmonte","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaci.2021.07.027_bib22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.stem.2019.05.011","article-title":"Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications","volume":"24","author":"Vatine","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jaci.2021.07.027_bib23","article-title":"Development and implementation of large-scale quality control for the European Bank for Induced Pluripotent Stem Cells","volume":"45","author":"O\u2019Shea","year":"2020","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jaci.2021.07.027_bib24","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jcyt.2019.03.574","article-title":"Establishing iPSC cell banks derived using reagents and workflows optimized for cell therapy manufacturing","volume":"21","author":"MacArthur","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaci.2021.07.027_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.alit.2017.08.008","article-title":"Mast cells derived from human induced pluripotent stem cells are useful for allergen tests","volume":"67","author":"Igarashi","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2021.07.027_bib26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2131\/jts.44.789","article-title":"Human induced pluripotent stem cell-derived mast cells useful for in\u00a0vitro mast cell activation assay exhibiting phenotypes and morphological characteristics of human mast cells","volume":"44","author":"Ikuno","year":"2019","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.jaci.2021.07.027_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.stemcr.2018.08.007","article-title":"Rapid mast cell generation from Gata2 reporter pluripotent stem cells","volume":"11","author":"Kauts","year":"2018","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jaci.2021.07.027_bib28","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.exphem.2017.06.101","article-title":"Stemdiff\u2122 hematopoietic kit reproducibly generates functional hematopoietic progenitor cells from human pluripotent stem cells","volume":"53","author":"Walasek","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2021.07.027_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-0716-0648-3_4","article-title":"Isolation and culture of human skin mast cells","volume":"2154","author":"Siiskonen","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaci.2021.07.027_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/cells8040341","article-title":"IL-33 and MRGPRX2-triggered activation of human skin mast cells\u2014elimination of receptor expression on chronic exposure, but reinforced degranulation on acute priming","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2021.07.027_bib31","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/all.14633","article-title":"Single-cell molecular profiling provides a high-resolution map of basophil and mast cell development","volume":"76","author":"Hamey","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.07.027_bib32","first-page":"1212","article-title":"Key regulators control distinct transcriptional programmes in blood progenitor and mast cells","volume":"33","author":"Calero-Nieto","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2021.07.027_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2015.07.016","article-title":"Murine and human mast cell progenitors","volume":"778","author":"Schmetzer","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2021.07.027_bib34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies","volume":"147","author":"K\u00fchn","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.07.027_bib35","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ajh.24553","article-title":"Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2021.07.027_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2021.07.027_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-0716-0648-3_4","article-title":"Isolation and culture of human skin mast cells","volume":"2154","author":"Siiskonen","year":"2020","journal-title":"Methods Mol Biol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492101201X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492101201X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:37:09Z","timestamp":1758793029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492101201X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S009167492101201X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.07.027","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel approach for studying mast cell\u2013driven disorders: Mast cells derived from induced pluripotent stem cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}